Vilnis Lietuvietis

Hipokrata Street 2
Riga, RIX LV1038, Latvia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Urinary Outcomes Following a Novel Reconstructive Pelvic Organ Prolapse Surgery: Randomized Controlled Trial.

Urinary Outcomes Following a Novel Reconstructive Pelvic Organ Prolapse Surgery: Randomized Controlled Trial.

Journal: Medicina (Kaunas, Lithuania)

Published: February 20, 2026

Testicular cancer in Latvia: incidence trends and prognostic outcomes across a 23-year study.

Testicular cancer in Latvia: incidence trends and prognostic outcomes across a 23-year study.

Journal: BMC cancer

Published: February 25, 2025

Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning.

Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning.

Journal: Diagnostics (Basel, Switzerland)

Published: December 01, 2024

Changes in TP53 Gene, Telomere Length, and Mitochondrial DNA in Benign Prostatic Hyperplasia Patients.

Changes in TP53 Gene, Telomere Length, and Mitochondrial DNA in Benign Prostatic Hyperplasia Patients.

Journal: Biomedicines

Published: July 08, 2024

Erratum: Accuracy of 68Ga-PSMA-11 PET/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer.

Erratum: Accuracy of 68Ga-PSMA-11 PET/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer.

Journal: American journal of nuclear medicine and molecular imaging

Published: March 14, 2024

Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.

Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.

Journal: The oncologist

Published: November 17, 2023

Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles.

Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles.

Journal: Frontiers in molecular biosciences

Published: August 18, 2023

Plasma and urinary extracellular vesicles as a source of RNA biomarkers for prostate cancer in liquid biopsies.

Plasma and urinary extracellular vesicles as a source of RNA biomarkers for prostate cancer in liquid biopsies.

Journal: Frontiers in molecular biosciences

Published: June 28, 2022

Management of a Giant Renal Artery Aneurysm in a Patient with Severe Hemophilia A.

Management of a Giant Renal Artery Aneurysm in a Patient with Severe Hemophilia A.

Journal: The American journal of case reports

Published: March 20, 2022

Clinicopathological Significance of Exosomal Proteins CD9 and CD63 and DNA Mismatch Repair Proteins in Prostate Adenocarcinoma and Benign Hyperplasia.

Clinicopathological Significance of Exosomal Proteins CD9 and CD63 and DNA Mismatch Repair Proteins in Prostate Adenocarcinoma and Benign Hyperplasia.

Journal: Diagnostics (Basel, Switzerland)

Published: December 30, 2021

Effects of urinary extracellular vesicles from prostate cancer patients on the transcriptomes of cancer-associated and normal fibroblasts.

Effects of urinary extracellular vesicles from prostate cancer patients on the transcriptomes of cancer-associated and normal fibroblasts.

Journal: BMC cancer

Published: September 27, 2021

The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries.

The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries.

Journal: International journal of environmental research and public health

Published: December 18, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026